171 related articles for article (PubMed ID: 26080696)
21. Fluorescence-labeled immunomicelles: preparation, in vivo biodistribution, and ability to cross the blood-brain barrier.
Yue J; Liu S; Wang R; Hu X; Xie Z; Huang Y; Jing X
Macromol Biosci; 2012 Sep; 12(9):1209-19. PubMed ID: 22807211
[TBL] [Abstract][Full Text] [Related]
22. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
Yoshikawa T; Pardridge WM
J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
[TBL] [Abstract][Full Text] [Related]
23. Brain targeting of Baicalin and Salvianolic acid B combination by OX26 functionalized nanostructured lipid carriers.
Wu Y; Song X; Kebebe D; Li X; Xue Z; Li J; Du S; Pi J; Liu Z
Int J Pharm; 2019 Nov; 571():118754. PubMed ID: 31604118
[TBL] [Abstract][Full Text] [Related]
24. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody.
Wu D; Pardridge WM
Drug Metab Dispos; 1998 Sep; 26(9):937-9. PubMed ID: 9733674
[TBL] [Abstract][Full Text] [Related]
26. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
27. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of brain-targeted chitosan nanoparticles through blood-brain barrier cerebral microvessel endothelial cells.
Sahin A; Yoyen-Ermis D; Caban-Toktas S; Horzum U; Aktas Y; Couvreur P; Esendagli G; Capan Y
J Microencapsul; 2017 Nov; 34(7):659-666. PubMed ID: 28862080
[TBL] [Abstract][Full Text] [Related]
29. Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.
Bu L; Gan LC; Guo XQ; Chen FZ; Song Q; Qi-Zhao ; Gou XJ; Hou SX; Yao Q
Int J Pharm; 2013 Aug; 452(1-2):355-62. PubMed ID: 23685116
[TBL] [Abstract][Full Text] [Related]
30. Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targeting.
El-Safy S; Tammam SN; Abdel-Halim M; Ali ME; Youshia J; Shetab Boushehri MA; Lamprecht A; Mansour S
Eur J Pharm Biopharm; 2020 Mar; 148():54-66. PubMed ID: 31945489
[TBL] [Abstract][Full Text] [Related]
31. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Giovino C; Ayensu I; Tetteh J; Boateng JS
Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rg1 nanoparticle penetrating the blood-brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction.
Shen J; Zhao Z; Shang W; Liu C; Zhang B; Zhao L; Cai H
Int J Nanomedicine; 2017; 12():6477-6486. PubMed ID: 28919749
[TBL] [Abstract][Full Text] [Related]
33. Transport of a caspase inhibitor across the blood-brain barrier by chitosan nanoparticles.
Yemişci M; Gürsoy-Özdemir Y; Caban S; Bodur E; Capan Y; Dalkara T
Methods Enzymol; 2012; 508():253-69. PubMed ID: 22449930
[TBL] [Abstract][Full Text] [Related]
34. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion.
Gosk S; Vermehren C; Storm G; Moos T
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1193-204. PubMed ID: 15545912
[TBL] [Abstract][Full Text] [Related]
35. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
Kang YS; Pardridge WM
J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
[TBL] [Abstract][Full Text] [Related]
36. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system.
Wu D; Pardridge WM
J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system.
Wu D; Song BW; Vinters HV; Pardridge WM
J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825
[TBL] [Abstract][Full Text] [Related]
38. Folate Receptor α-Modified Nanoparticles for Targeting of the Central Nervous System.
Kuplennik N; Lang K; Steinfeld R; Sosnik A
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39633-39647. PubMed ID: 31532618
[TBL] [Abstract][Full Text] [Related]
39. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
Kang YS; Jung HJ; Oh JS; Song DY
CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.
Kang YS; Bickel U; Pardridge WM
Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
